Search Within

Yingbei Chen

  1. "Biostatistics Service"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (15)
Groups
  1. Biostatistics Service (37)
  2. Department of Pathology and Laboratory Medicine (37)
  3. Epidemiology and Biostatistics (37)
  4. Department of Medicine (32)
  5. Genitourinary Oncology Service (32)
  6. Solid Tumor Oncology Division (32)

More Groups

People
  1. Martin Voss (22)
  2. Robert Motzer (22)
  3. Victor Reuter (22)
  4. Abraham Hakimi (20)
  5. Satish Tickoo (20)
  6. Irina Ostrovnaya (17)

More People

Years
  1. 2024 (1)
  2. 2022 (4)
  3. 2021 (2)
  4. 2020 (2)
  5. 2019 (6)
  6. 2018 (4)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Clinical Genitourinary Cancer (4)
  3. Modern Pathology (4)
  4. Clinical Cancer Research (3)
  5. Laboratory Investigation (3)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (5)
  3. Elsevier Inc. (5)
  4. Nature Publishing Group (5)
  5. Nature Research (4)
  6. Wiley Blackwell (2)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network
    Journal Article

    Hakimi, A. A.; Ostrovnaya, I.; Reva, B.; Schultz, N.; Chen, Y. B.; Gonen, M.; Liu, H.; Takeda, S.; Voss, M. H.; Tickoo, S. K.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; Reuter, V. E.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • Mutations of 3p21 epigenetic regulators in clear cell renal cell carcinoma: Sequencing and clinicopathologic analysis of 188 cases
    Meeting Abstract

    Huang, H.; Hakimi, A. A.; Ostrovnaya, I.; Al-Ahmadie, H. A.; Gopalan, A.; Fine, S. W.; Hsieh, J. J.; Reuter, V. E.; Tickoo, S. K.; Chen, Y. B.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Mutations of 3p21 epigenetic regulators in clear cell renal cell carcinoma: Sequencing and clinicopathologic analysis of 188 cases
    Meeting Abstract

    Huang, H.; Hakimi, A. A.; Ostrovnaya, I.; Al-Ahmadie, H. A.; Gopalan, A.; Fine, S. W.; Hsieh, J. J.; Reuter, V. E.; Tickoo, S. K.; Chen, Y. B.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
    BJU International (2012)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry with FISH for detection of TMPRSS2-ERG rearrangement in prostate cancers in African American and Caucasian populations
    Meeting Abstract

    Elliott, R. M.; Leversha, M. A.; Satagopan, J. M.; Zhou, Q. C.; Dudas, M.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S.; Tickoo, S.; Eastham, J. A.; more...
    Modern Pathology (2011)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry with FISH for detection of TMPRSS2-ERG rearrangement in prostate cancers in African American and Caucasian populations
    Meeting Abstract

    Elliott, R. M.; Leversha, M. A.; Satagopan, J. M.; Zhou, Q.; Dudas, M.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S.; Tickoo, S.; Eastham, J. A.; more...
    Laboratory Investigation (2011)

    Fulltext@MSK | Save